FDA NDC
Imipramine Pamoate
This name is from the loaded FDA file.
Source: FDA NDC Directory, live from openFDA. Publisher page
- NDC
- 0054-0275
- Proprietary name
- Imipramine Pamoate
- Nonproprietary name
- Imipramine Pamoate
- Labeler
- Hikma Pharmaceuticals USA Inc
- Dosage form
- CAPSULE
- Strength
- 125 mg/1
Run it in Rivvi
Which 2027 plans near you dropped or restricted Imipramine Pamoate?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan, from the CMS Part D files.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.